Related Experiment Videos
Outcome of Chlamydia pneumoniae associated acute ischemic stroke in elderly patients: a case-control study
V C S Srinivasarao Bandaru1, Demudu Babu Boddu, K Rukmini Mridula
1Department of Clinical Research, Yashoda Hospital, Somajiguda, Hyderabad 500082, India.
Insights
Chlamydia pneumoniae infection is linked to ischemic stroke in elderly patients. However, the presence of C. pneumoniae antibodies does not affect stroke outcomes in this population.
Area of Science:
- Infectious Diseases
- Neurology
- Geriatrics
Background:
- Limited data exists on the role of Chlamydia pneumoniae in elderly patients experiencing acute ischemic stroke.
- Investigating potential infectious triggers for stroke in older adults is crucial for understanding disease mechanisms.
Purpose of the Study:
- To investigate the association between Chlamydia pneumoniae infection and acute ischemic stroke in elderly individuals (over 65 years).
- To determine the impact of C. pneumoniae infection on stroke outcomes in this demographic.
Main Methods:
- A case-control study involving 100 elderly acute ischemic stroke patients and 100 age/sex-matched controls.
- Measurement of IgG and IgA anti-C. pneumoniae antibodies using microimmunofluorescence.
- Good stroke outcome defined as a Modified Rankin score (mRS) of ≤2 at 90-day follow-up.
Main Results:
- Chlamydia pneumoniae antibodies were detected in 35% of stroke patients versus 18% of controls (p=0.01).
- No significant difference in good outcomes at 90 days was observed between seropositive (57.1%) and seronegative (56.9%) stroke patients (p=0.9).
Conclusions:
- Chlamydia pneumoniae antibody positivity is independently associated with acute ischemic stroke in the elderly.
- C. pneumoniae infection does not appear to influence the short-term outcome of ischemic stroke in elderly patients.
Background:
Limited data exists about the role of Chlamydia pneumoniae elderly patients with acute ischemic stroke.
Objective:
To study the role of C. pneumoniae in elderly patients (age more than 65 years) with acute ischemic stroke and its impact on stroke out come.
Methods:
We recruited 100 elderly patients with acute ischemic stroke and 100 age and sex matched controls over a period of 2 years. IgG and IgA anti C. pneumoniae antibodies were measured by microimmunofluorescence technique in patients and controls. Good outcome was defined as a Modified Rankin score (mRS) of ≤2.
Results:
We found C. pneumoniae antibodies in 35% stroke patients and in 18% control subjects (p=0.01). Good out come at 90 days follow up was found in 20/35(57.1%) seropositive stroke patients compared to 37/65(56.9%) seronegative stroke patients (p=0.9).
Conclusions:
C. pneumoniae antibody positivity was independently associated with ischemic stroke in elderly patients and its presence does not alter the stroke outcome.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Phylum Chlamydiae